“…Benzimidazolyl heterocycle is also considered for conjugation with the targeted compounds due to the diverse biological properties exhibited by its derivatives such as antitumor [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , anti-inflammatory [32] , antitubercular [33] , [34] , [35] , anti-HIV (human immunodeficiency virus) [36] , [37] , [38] , α -glucosidase inhibition [39] , [40] , [41] , cholinesterase inhibitor useful to combat the neuromuscular disorders [42] , pancreatic lipase inhibitor useful for fat absorption control [43] , α -amylase inhibitor useful for diabetes, obesity, and oral diseases [44] and Rho-kinase inhibitor useful for treatment of glaucoma [45] . Treanda (Bendamustine hydrochloride) is a benzimidazolyl derivative approved by FDA (2008) for chronic lymphocytic leukemia [46] , [47] .…”